Liver damage associated with perhexiline maleate.
Open Access
- 1 March 1979
- Vol. 20 (3) , 186-189
- https://doi.org/10.1136/gut.20.3.186
Abstract
Two patients who developed biochemical and histological evidence of hepatitis while taking the anti-anginal drug perhexiline maleate are described. The pathological changes were those of mild to moderate fatty change together with a hepatitis which resembled alcoholic hepatitis, including in one patient the presence of material which by light microscopy was indistinguishable from Mallory's alcoholic hyalin. However, the predominantly periportal location of this material contrasted with the centrilobular distribution of Mallory's hyaline. One patient showed, in addition, severe atypia of the hepatocytes which was still present in less pronounced form 10 weeks after stopping perhexiline. The other patient had advanced hepatic fibrosis.This publication has 13 references indexed in Scilit:
- LIVER DAMAGE AFTER PERHEXILINE MALEATEThe Lancet, 1977
- LIVER DAMAGE AFTER PERHEXILINE MALEATEThe Lancet, 1977
- LIVER GANGLIOSIDE STORAGE AFTER PERHEXILINE MALEATEThe Lancet, 1977
- [Letter: Hepatitis medicamentosa caused by perhexiline].1976
- Polyneuropathy after perhexiline maleate therapy.BMJ, 1976
- Long-term perhexiline maleate and liver function.BMJ, 1976
- [Letter: Hypoglycemia and perhexilline].1974
- Primary carcinoma of the liver: A study of 282 cases in Ugandan AfricansThe Journal of Pathology, 1973
- Proceedings: Long-term assessment of perhexiline maleate in angina pectoris.1973
- Proceedings: Assessment of safety data from patients on short and long-term perhexiline therapy.1973